BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11457519)

  • 21. Cholecystokinin: a putative satiety signal.
    Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):135-8. PubMed ID: 1226392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK).
    Burton-Freeman BM
    Physiol Behav; 2008 Jan; 93(1-2):379-87. PubMed ID: 17964616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of food intake and growth of swine by cholecystokinin immunization.
    Pekas JC; Trout WE
    Growth Dev Aging; 1990; 54(1-2):51-6. PubMed ID: 2210922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hyperglycemia on the satiating effect of CCK in humans.
    Lam WF; Gielkens HA; de Boer SY; Lamers CB; Masclee AA
    Physiol Behav; 1998 Dec; 65(3):505-11. PubMed ID: 9877417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats.
    Smith GP; Greenberg D; Falasco JD; Avilion AA; Gibbs J; Liddle RA; Williams JA
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1462-6. PubMed ID: 2604005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis.
    Ebenezer IS
    Eur J Pharmacol; 2003 Feb; 461(2-3):113-8. PubMed ID: 12586206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut peptides in the control of food intake.
    Moran TH
    Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S7-10. PubMed ID: 19363513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against cholecystokinin decreases appetite in lambs.
    Spencer GS
    J Anim Sci; 1992 Dec; 70(12):3820-4. PubMed ID: 1474019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans.
    Drewe J; Gadient A; Rovati LC; Beglinger C
    Gastroenterology; 1992 May; 102(5):1654-9. PubMed ID: 1568575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidergic control of food intake in food-producing animals.
    Baile CA; Della-Fera MA
    Fed Proc; 1984 Nov; 43(14):2898-902. PubMed ID: 6092147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH; Gibbs J; Smith GP
    Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut peptides and postprandial satiety.
    Smith GP; Gibbs J
    Fed Proc; 1984 Nov; 43(14):2889-92. PubMed ID: 6149153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice.
    Geary N; Asarian L; Korach KS; Pfaff DW; Ogawa S
    Endocrinology; 2001 Nov; 142(11):4751-7. PubMed ID: 11606440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic glucagon and cholecystokinin synergistically inhibit sham feeding in rats.
    Le Sauter J; Geary N
    Am J Physiol; 1987 Nov; 253(5 Pt 2):R719-25. PubMed ID: 3688274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.